Objectives: Our purpose was to demonstrate that strategically chosen implantable
cardioverter-defibrillator (ICD) ventricular tachycardia (VT) or ventricular fibrillation (VF) …

Focuses on the antitachycardia pacing for ventricular tachycardia. Use of implantable
cardioverter defibrillators on ventricular tachycardia; Pathophysiological basis for sustained …

Background—Implantable cardioverter defibrillators (ICDs) reduce mortality in primary and
secondary prevention. Quality of life, mortality, appropriate therapies for specific ventricular …

Objectives: The purpose of this randomized study was to determine whether a strategically
chosen standardized set of programmable settings is at least as effective as physician …

Background—Fifty percent of deaths in patients with coronary disease occur suddenly.
Although many factors correlate with increased mortality, there is little information regarding …

Antiarrhythmic drugs need to be initiated in up to 70% of patients with implantable
cardioverter-defibrillators (ICDs) in order to treat atrial tachyarrhythmias, decrease the …

Background—The tachycardia detection interval (TDI) in implantable cardioverter/
defibrillators (ICDs) is conventionally programmed according to the slowest documented …

Clinical variables predicting inappropriate use of implantable cardioverter-defibrillator in
patients with coronary heart disease or nonischemic dilated cardiomyopathy …

Background—This study aims to assess the incidence and clinical relevance of slow
ventricular tachycardia (VT) and the effectiveness and/or deleterious effects of …

The article offers a guide to advanced implantable cardioverter defibrillator (ICD)
troubleshooting. The guide covers various ICD problems such as failure to deliver therapy or …